ID   GLNA_BACSU              Reviewed;         444 AA.
AC   P12425;
DT   01-OCT-1989, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   22-JUL-2015, entry version 133.
DE   RecName: Full=Glutamine synthetase;
DE            EC=6.3.1.2;
DE   AltName: Full=Glutamate--ammonia ligase;
GN   Name=glnA; OrderedLocusNames=BSU17460;
OS   Bacillus subtilis (strain 168).
OC   Bacteria; Firmicutes; Bacilli; Bacillales; Bacillaceae; Bacillus.
OX   NCBI_TaxID=224308;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2906311; DOI=10.1016/0378-1119(88)90042-X;
RA   Strauch M.A., Aronson A.I., Brown S.W., Schreier H.J.,
RA   Sonenshein A.L.;
RT   "Sequence of the Bacillus subtilis glutamine synthetase gene region.";
RL   Gene 71:257-265(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND PROTEIN SEQUENCE OF 2-21.
RC   STRAIN=ATCC 6633 / PCI 219 / NRS 231;
RX   PubMed=2565853; DOI=10.1016/0378-1097(89)90151-1;
RA   Nakano Y., Tanaka E., Kato C., Kimura K., Horikoshi K.;
RT   "The complete nucleotide sequence of the glutamine synthetase gene
RT   (glnA) of Bacillus subtilis.";
RL   FEMS Microbiol. Lett. 48:81-86(1989).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Borchert S., Klein C., Piksa B., Hammelmann M., Entian K.-D.;
RT   "Sequencing of a 26 kb region of the Bacillus subtilis genome
RT   downstream of spoVJ.";
RL   Submitted (FEB-1997) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=168;
RX   PubMed=9384377; DOI=10.1038/36786;
RA   Kunst F., Ogasawara N., Moszer I., Albertini A.M., Alloni G.,
RA   Azevedo V., Bertero M.G., Bessieres P., Bolotin A., Borchert S.,
RA   Borriss R., Boursier L., Brans A., Braun M., Brignell S.C., Bron S.,
RA   Brouillet S., Bruschi C.V., Caldwell B., Capuano V., Carter N.M.,
RA   Choi S.-K., Codani J.-J., Connerton I.F., Cummings N.J., Daniel R.A.,
RA   Denizot F., Devine K.M., Duesterhoeft A., Ehrlich S.D., Emmerson P.T.,
RA   Entian K.-D., Errington J., Fabret C., Ferrari E., Foulger D.,
RA   Fritz C., Fujita M., Fujita Y., Fuma S., Galizzi A., Galleron N.,
RA   Ghim S.-Y., Glaser P., Goffeau A., Golightly E.J., Grandi G.,
RA   Guiseppi G., Guy B.J., Haga K., Haiech J., Harwood C.R., Henaut A.,
RA   Hilbert H., Holsappel S., Hosono S., Hullo M.-F., Itaya M.,
RA   Jones L.-M., Joris B., Karamata D., Kasahara Y., Klaerr-Blanchard M.,
RA   Klein C., Kobayashi Y., Koetter P., Koningstein G., Krogh S.,
RA   Kumano M., Kurita K., Lapidus A., Lardinois S., Lauber J.,
RA   Lazarevic V., Lee S.-M., Levine A., Liu H., Masuda S., Mauel C.,
RA   Medigue C., Medina N., Mellado R.P., Mizuno M., Moestl D., Nakai S.,
RA   Noback M., Noone D., O'Reilly M., Ogawa K., Ogiwara A., Oudega B.,
RA   Park S.-H., Parro V., Pohl T.M., Portetelle D., Porwollik S.,
RA   Prescott A.M., Presecan E., Pujic P., Purnelle B., Rapoport G.,
RA   Rey M., Reynolds S., Rieger M., Rivolta C., Rocha E., Roche B.,
RA   Rose M., Sadaie Y., Sato T., Scanlan E., Schleich S., Schroeter R.,
RA   Scoffone F., Sekiguchi J., Sekowska A., Seror S.J., Serror P.,
RA   Shin B.-S., Soldo B., Sorokin A., Tacconi E., Takagi T., Takahashi H.,
RA   Takemaru K., Takeuchi M., Tamakoshi A., Tanaka T., Terpstra P.,
RA   Tognoni A., Tosato V., Uchiyama S., Vandenbol M., Vannier F.,
RA   Vassarotti A., Viari A., Wambutt R., Wedler E., Wedler H.,
RA   Weitzenegger T., Winters P., Wipat A., Yamamoto H., Yamane K.,
RA   Yasumoto K., Yata K., Yoshida K., Yoshikawa H.-F., Zumstein E.,
RA   Yoshikawa H., Danchin A.;
RT   "The complete genome sequence of the Gram-positive bacterium Bacillus
RT   subtilis.";
RL   Nature 390:249-256(1997).
RN   [5]
RP   INTERACTION WITH TNRA.
RX   PubMed=11719184; DOI=10.1016/S0092-8674(01)00572-4;
RA   Wray L.V. Jr., Zalieckas J.M., Fisher S.H.;
RT   "Bacillus subtilis glutamine synthetase controls gene expression
RT   through a protein-protein interaction with transcription factor
RT   TnrA.";
RL   Cell 107:427-435(2001).
CC   -!- CATALYTIC ACTIVITY: ATP + L-glutamate + NH(3) = ADP + phosphate +
CC       L-glutamine.
CC   -!- ENZYME REGULATION: The activity of this enzyme is controlled by
CC       adenylation under conditions of abundant glutamine. The fully
CC       adenylated enzyme complex is inactive (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Oligomer of 12 subunits arranged in the form of two
CC       hexagons. In its feedback-inhibited form, interacts with TnrA in
CC       order to block its DNA-binding activity. This inhibitory effect is
CC       the highest when both glutamine and AMP are present.
CC       {ECO:0000269|PubMed:11719184}.
CC   -!- INTERACTION:
CC       Q45666:tnrA; NbExp=8; IntAct=EBI-6402863, EBI-8507041;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- INDUCTION: Repressed by GlnR under conditions of nitrogen excess.
CC       Repressed by TnrA under conditions of nitrogen limitation.
CC   -!- MISCELLANEOUS: Elevated Mn(2+) concentration reduces sensitivity
CC       of GlnA to feedback inhibitors Gln and AMP.
CC   -!- SIMILARITY: Belongs to the glutamine synthetase family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M22811; AAA83376.1; -; Genomic_DNA.
DR   EMBL; D00854; BAA00730.1; -; Genomic_DNA.
DR   EMBL; U66480; AAB41080.1; -; Genomic_DNA.
DR   EMBL; AL009126; CAB13630.1; -; Genomic_DNA.
DR   PIR; JT0392; AJBSQS.
DR   RefSeq; NP_389628.1; NC_000964.3.
DR   RefSeq; WP_003231737.1; NZ_JNCM01000035.1.
DR   PDB; 2FWX; Model; -; A/B/C/D=1-444.
DR   PDB; 3QAJ; X-ray; 3.05 A; A/B/C/D/E/F/G/H/I/J/K/L=1-444.
DR   PDB; 4LNF; X-ray; 2.95 A; A/B/C/D/E/F/G/H/I/J/K/L=2-444.
DR   PDB; 4LNI; X-ray; 2.58 A; A/B/C/D/E/F/G/H/I/J/K/L=2-444.
DR   PDB; 4LNK; X-ray; 2.87 A; A/B/C/D/E/F=2-444.
DR   PDB; 4LNN; X-ray; 3.10 A; A/B/C/D/E/F/G/H/I/J/K/L=2-444.
DR   PDB; 4LNO; X-ray; 2.90 A; A/B/C/D/E/F=2-444.
DR   PDB; 4S0R; X-ray; 3.50 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N=1-444.
DR   PDBsum; 2FWX; -.
DR   PDBsum; 3QAJ; -.
DR   PDBsum; 4LNF; -.
DR   PDBsum; 4LNI; -.
DR   PDBsum; 4LNK; -.
DR   PDBsum; 4LNN; -.
DR   PDBsum; 4LNO; -.
DR   PDBsum; 4S0R; -.
DR   ProteinModelPortal; P12425; -.
DR   SMR; P12425; 5-443.
DR   DIP; DIP-29670N; -.
DR   IntAct; P12425; 4.
DR   MINT; MINT-224371; -.
DR   STRING; 224308.Bsubs1_010100009606; -.
DR   PaxDb; P12425; -.
DR   EnsemblBacteria; CAB13630; CAB13630; BSU17460.
DR   GeneID; 940020; -.
DR   KEGG; bsu:BSU17460; -.
DR   PATRIC; 18975307; VBIBacSub10457_1845.
DR   GenoList; BSU17460; -.
DR   eggNOG; COG0174; -.
DR   HOGENOM; HOG000005156; -.
DR   InParanoid; P12425; -.
DR   KO; K01915; -.
DR   OMA; LQFVDIF; -.
DR   OrthoDB; EOG6B360N; -.
DR   PhylomeDB; P12425; -.
DR   BioCyc; BSUB:BSU17460-MONOMER; -.
DR   BRENDA; 6.3.1.2; 658.
DR   SABIO-RK; P12425; -.
DR   Proteomes; UP000001570; Chromosome.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004356; F:glutamate-ammonia ligase activity; IEA:UniProtKB-EC.
DR   GO; GO:0006542; P:glutamine biosynthetic process; IMP:CACAO.
DR   GO; GO:0009399; P:nitrogen fixation; IEA:InterPro.
DR   Gene3D; 3.10.20.70; -; 1.
DR   Gene3D; 3.30.590.10; -; 1.
DR   InterPro; IPR008147; Gln_synt_beta.
DR   InterPro; IPR014746; Gln_synth/guanido_kin_cat_dom.
DR   InterPro; IPR008146; Gln_synth_cat_dom.
DR   InterPro; IPR027303; Gln_synth_gly_rich_site.
DR   InterPro; IPR004809; Gln_synth_I.
DR   InterPro; IPR001637; Gln_synth_I_adenylation_site.
DR   InterPro; IPR027302; Gln_synth_N_conserv_site.
DR   Pfam; PF00120; Gln-synt_C; 1.
DR   Pfam; PF03951; Gln-synt_N; 1.
DR   SUPFAM; SSF54368; SSF54368; 1.
DR   TIGRFAMs; TIGR00653; GlnA; 1.
DR   PROSITE; PS00180; GLNA_1; 1.
DR   PROSITE; PS00182; GLNA_ADENYLATION; 1.
DR   PROSITE; PS00181; GLNA_ATP; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Ligase; Nucleotide-binding; Phosphoprotein;
KW   Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000269|PubMed:2565853}.
FT   CHAIN         2    444       Glutamine synthetase.
FT                                /FTId=PRO_0000153233.
FT   MOD_RES     373    373       O-AMP-tyrosine. {ECO:0000250}.
FT   VARIANT      10     10       E -> V (in strain: PCI 219).
FT   VARIANT      43     43       G -> E (in strain: PCI 219).
FT   VARIANT     253    253       N -> D (in strain: PCI 219).
FT   VARIANT     259    259       F -> Y (in strain: PCI 219).
FT   HELIX         6     16       {ECO:0000244|PDB:4LNI}.
FT   STRAND       20     26       {ECO:0000244|PDB:4LNI}.
FT   STRAND       28     30       {ECO:0000244|PDB:4S0R}.
FT   STRAND       32     38       {ECO:0000244|PDB:4LNI}.
FT   HELIX        39     41       {ECO:0000244|PDB:4LNI}.
FT   HELIX        42     46       {ECO:0000244|PDB:4LNI}.
FT   STRAND       51     53       {ECO:0000244|PDB:4LNI}.
FT   HELIX        54     56       {ECO:0000244|PDB:4LNI}.
FT   HELIX        59     61       {ECO:0000244|PDB:4S0R}.
FT   HELIX        63     65       {ECO:0000244|PDB:4LNI}.
FT   STRAND       67     80       {ECO:0000244|PDB:4LNI}.
FT   HELIX        81     83       {ECO:0000244|PDB:4LNI}.
FT   HELIX        84     87       {ECO:0000244|PDB:4LNI}.
FT   STRAND       89     97       {ECO:0000244|PDB:4LNI}.
FT   STRAND       99    103       {ECO:0000244|PDB:4LNK}.
FT   HELIX       108    121       {ECO:0000244|PDB:4LNI}.
FT   STRAND      125    133       {ECO:0000244|PDB:4LNI}.
FT   STRAND      135    140       {ECO:0000244|PDB:4LNI}.
FT   STRAND      142    144       {ECO:0000244|PDB:4LNN}.
FT   STRAND      146    151       {ECO:0000244|PDB:4LNI}.
FT   TURN        160    162       {ECO:0000244|PDB:4LNI}.
FT   STRAND      163    165       {ECO:0000244|PDB:4LNK}.
FT   HELIX       166    178       {ECO:0000244|PDB:4LNI}.
FT   STRAND      183    188       {ECO:0000244|PDB:4LNI}.
FT   STRAND      194    199       {ECO:0000244|PDB:4LNI}.
FT   HELIX       204    224       {ECO:0000244|PDB:4LNI}.
FT   STRAND      227    230       {ECO:0000244|PDB:4LNI}.
FT   STRAND      244    252       {ECO:0000244|PDB:4LNI}.
FT   STRAND      261    263       {ECO:0000244|PDB:4LNK}.
FT   HELIX       264    266       {ECO:0000244|PDB:4LNI}.
FT   HELIX       269    289       {ECO:0000244|PDB:4LNI}.
FT   HELIX       295    298       {ECO:0000244|PDB:4LNI}.
FT   STRAND      311    313       {ECO:0000244|PDB:4LNI}.
FT   STRAND      316    322       {ECO:0000244|PDB:4LNI}.
FT   HELIX       327    329       {ECO:0000244|PDB:4LNI}.
FT   STRAND      332    334       {ECO:0000244|PDB:4LNI}.
FT   HELIX       343    359       {ECO:0000244|PDB:4LNI}.
FT   HELIX       372    374       {ECO:0000244|PDB:4LNI}.
FT   HELIX       377    383       {ECO:0000244|PDB:4LNI}.
FT   HELIX       392    400       {ECO:0000244|PDB:4LNI}.
FT   HELIX       403    409       {ECO:0000244|PDB:4LNI}.
FT   HELIX       411    430       {ECO:0000244|PDB:4LNI}.
FT   HELIX       434    440       {ECO:0000244|PDB:4LNI}.
FT   TURN        441    443       {ECO:0000244|PDB:4LNI}.
SQ   SEQUENCE   444 AA;  50278 MW;  83A5657CE1388AB0 CRC64;
     MAKYTREDIE KLVKEENVKY IRLQFTDILG TIKNVEIPVS QLGKALDNKV MFDGSSIEGF
     VRIEESDMYL YPDLNTFVIF PWTAEKGKVA RFICDIYNPD GTPFEGDPRN NLKRILKEME
     DLGFSDFNLG PEPEFFLFKL DEKGEPTLEL NDKGGYFDLA PTDLGENCRR DIVLELEEMG
     FEIEASHHEV APGQHEIDFK YAGAVRSCDD IQTFKLVVKT IARKHGLHAT FMPKPLFGVN
     GSGMHCNLSL FKNGVNAFFD ENADLQLSET AKHFIAGIVK HATSFTAVTN PTVNSYKRLV
     PGYEAPCYVA WSAQNRSPLI RIPASRGIST RVEVRSVDPA ANPYLALSVL LAAGLDGIKN
     KLEAPAPIDR NIYVMSKEER MENGIVDLPA TLAEALEEFK SNEVMVKALG EHLFEHFIEA
     KEIEWDMFRT QVHPWEREQY MSQY
//
